DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aggrenox (Aspirin / Extended-Release Dipyridamole) - Current Clinical Trials


Aggrenox Related Clinical Trials

Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers [Completed]

Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers [Completed]

Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers [Completed]

JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme [Completed]

Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH [Completed]

EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA [Completed]

Headache Study to Compare Aggrenox Full Dose and Reduced Dose [Completed]

Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects [Completed]

Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects [Terminated]

Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers [Completed]

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects [Completed]

Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects [Completed]

Pharmacokinetics and Safety of Asasantin Extended Release (RAD-SP) Capsules in Japanese Healthy Male Volunteers [Completed]

Tolerability of Asasantin in Healthy Female and Male Subjects [Completed]

Vascular Access Clinical Trials Data Coordinating Center [Completed]

Treatment of Supine Hypertension in Autonomic Failure [Recruiting]

Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers [Completed]

Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects [Completed]

Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers [Completed]

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients [Completed]

Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) [Active, not recruiting]

GORE® HELEX® Septal Occluder / GORE® Septal Occluder for Patent Foramen Ovale (PFO) Closure in Stroke Patients - The Gore REDUCE Clinical Study [Active, not recruiting]

Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence [Active, not recruiting]

Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017